S83130 |
GV-58 |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: GV-58 is a novel N- and P/Q-type calcium (Ca2+) channel agonist with EC50s of 7.21 and 8.81 μM, respectively. GV-58 slows the deactivation of channels, resulting in a large increase in presynaptic Ca2+ entry during activity. GV-58 can be used in lambert-eaton myasthenic syndrome (LEMS) research
- 靶点: N-type calcium channel:7.21 μM (EC50);P/Q-type calcium channel:8.81 μM (EC50);CalciumChannel
- 体外研究:
GV-58 (50 μM; 30 min) restores function in LEMS passive transfer neuromuscular junction. Cell Viability Assay Cell Line: Upper arm muscle isolated from LEMS mice Concentration: 50 μM Incubation Time: 30 min Result: Increased the mEPP frequency from 3.27 s−1 in vehicle controls to 10.45 s−1.Showed a slight facilitation followed by depression to ∼94% at the final EPP in the train.
- 参考文献:
1. Tarr TB, et al. Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome. J Neurosci. 2013 Jun 19;33(25):10559-67. 2. Tarr TB, et al. Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist. J Physiol. 2014 Aug 15;592(16):3687-96. 3. Meriney SD, et al. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads. Ann N Y Acad Sci. 2018 Jan;1412(1):73-81.
- 溶解性: Soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.67 ml 13.351 ml 26.702 ml 5 mM 0.534 ml 2.67 ml 5.34 ml 10 mM 0.267 ml 1.335 ml 2.67 ml 50 mM 0.053 ml 0.267 ml 0.534 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)